| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.55 | 0.014 | 0.55 | GABA C receptor rho-3 antagonist | |||
| 0.531 | 0.012 | 0.571 | Hypoxia-inducible factor 1 alpha inhibitor | 0.571 0.009 CID_154699997 | CID_154699997 | |
| 0.493 | 0.014 | 0.493 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.149 0.131 CID_154699997 | ||
| 0.496 | 0.019 | 0.496 | MAP kinase kinase 6 inhibitor | 0.273 0.163 CID_154699997 | ||
| 0.475 | 0.016 | 0.475 | Dyrk kinase inhibitor | |||
| 0.43 | 0.06 | 0.525 | Histamine release inhibitor | 0.525 0.021 CID_154699997 | CID_154699997 | |
| 0.387 | 0.02 | 0.387 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.386 | 0.019 | 0.386 | RNA-directed DNA polymerase inhibitor | 0.31 0.03 CID_154699997 | ||
| 0.375 | 0.018 | 0.375 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.401 | 0.06 | 0.401 | Toll-Like receptor agonist | 0.337 0.089 CID_154699997 | ||
| 0.337 | 0.014 | 0.337 | LIM domain kinase 1 inhibitor | |||
| 0.362 | 0.05 | 0.362 | Nootropic | |||
| 0.336 | 0.031 | 0.336 | Peroxidase inhibitor | |||
| 0.333 | 0.031 | 0.333 | Clk dual-specificity kinase inhibitor | |||
| 0.333 | 0.033 | 0.333 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.363 | 0.066 | 0.424 | Angiogenesis inhibitor | 0.424 0.046 CID_154699997 | CID_154699997 | |
| 0.319 | 0.033 | 0.319 | Death-associated protein kinase 3 inhibitor | |||
| 0.312 | 0.037 | 0.467 | Cyclic AMP phosphodiesterase inhibitor | 0.467 0.009 CID_154699997 | CID_154699997 | |
| 0.329 | 0.059 | 0.329 | Aldehyde oxidase inhibitor | |||
| 0.292 | 0.026 | 0.292 | Protein kinase C nu inhibitor | |||
| 0.284 | 0.023 | 0.284 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.345 | 0.085 | 0.345 | Toll-Like receptor 7 agonist | 0.279 0.124 CID_154699997 | ||
| 0.286 | 0.035 | 0.286 | CDC-like kinase 2 inhibitor | |||
| 0.393 | 0.143 | 0.736 | Antiinflammatory | 0.736 0.025 CID_154699997 | CID_154699997 | |
| 0.262 | 0.015 | 0.262 | TRKB antagonist | |||
| 0.265 | 0.018 | 0.265 | Activin receptor-like kinase 2 inhibitor | |||
| 0.272 | 0.027 | 0.272 | I kappa B kinase epsilon inhibitor | |||
| 0.275 | 0.03 | 0.275 | Src kinase inhibitor | |||
| 0.263 | 0.022 | 0.263 | Lck kinase inhibitor | |||
| 0.269 | 0.04 | 0.269 | TRKC antagonist | |||
| 0.294 | 0.068 | 0.294 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.24 | 0.02 | 0.24 | CDC-like kinase 1 inhibitor | |||
| 0.224 | 0.009 | 0.224 | ALK inhibitor | |||
| 0.264 | 0.051 | 0.264 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.22 | 0.007 | 0.22 | Folate antagonist | 0.186 0.012 CID_154699997 | ||
| 0.251 | 0.038 | 0.256 | Neurotrophic factor enhancer | 0.256 0.035 CID_154699997 | CID_154699997 | |
| 0.24 | 0.03 | 0.24 | Heat shock protein 90 alpha antagonist | |||
| 0.266 | 0.057 | 0.425 | DNA synthesis inhibitor | 0.425 0.019 CID_154699997 | CID_154699997 | |
| 0.233 | 0.026 | 0.233 | Heat shock protein 90 antagonist | |||
| 0.257 | 0.052 | 0.257 | Tyrosine kinase inhibitor | |||
| 0.215 | 0.01 | 0.215 | Protein kinase C zeta inhibitor | |||
| 0.249 | 0.046 | 0.249 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.227 | 0.027 | 0.227 | Ribosomal protein S6 kinase inhibitor | 0.116 0.095 CID_154699997 | ||
| 0.211 | 0.012 | 0.211 | Protein kinase C gamma inhibitor | |||
| 0.211 | 0.014 | 0.211 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.145 0.082 CID_154699997 | ||
| 0.208 | 0.011 | 0.208 | MAP kinase kinase 4 inhibitor | 0.134 0.102 CID_154699997 | ||
| 0.228 | 0.035 | 0.228 | Protein kinase (CK1) gamma inhibitor | |||
| 0.2 | 0.009 | 0.469 | DNA repair enzyme inhibitor | 0.469 0.003 CID_154699997 | CID_154699997 | |
| 0.237 | 0.051 | 0.237 | CDC-like kinase 4 inhibitor | |||
| 0.219 | 0.036 | 0.219 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.216 | 0.035 | 0.216 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.225 | 0.057 | 0.225 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.231 | 0.063 | 0.231 | MAP kinase kinase 2 inhibitor | |||
| 0.205 | 0.044 | 0.205 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.191 | 0.031 | 0.191 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.189 | 0.031 | 0.189 | Abl kinase inhibitor | |||
| 0.181 | 0.024 | 0.203 | Beta amyloid protein antagonist | 0.203 0.016 CID_154699997 | CID_154699997 | |
| 0.178 | 0.022 | 0.178 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.155 | 0.008 | 0.155 | mTOR complex 2 inhibitor | |||
| 0.175 | 0.029 | 0.175 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.189 | 0.044 | 0.189 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.161 | 0.016 | 0.161 | Platelet growth factor antagonist | |||
| 0.163 | 0.021 | 0.163 | Protein kinase C mu inhibitor | |||
| 0.183 | 0.044 | 0.183 | Toll-Like receptor 9 antagonist | |||
| 0.15 | 0.012 | 0.15 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.15 | 0.014 | 0.15 | Toll-Like receptor 3 antagonist | |||
| 0.179 | 0.043 | 0.179 | GABA C receptor rho-2 antagonist | |||
| 0.179 | 0.049 | 0.179 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.184 | 0.055 | 0.184 | Polo-like kinase-3 inhibitor | |||
| 0.21 | 0.081 | 0.21 | EphB2 antagonist | |||
| 0.142 | 0.014 | 0.142 | mTOR complex 1 inhibitor | |||
| 0.206 | 0.08 | 0.206 | Nitric-oxide synthase stimulant | 0.204 0.082 CID_154699997 | ||
| 0.168 | 0.042 | 0.168 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.17 | 0.045 | 0.17 | c-Src kinase inhibitor | |||
| 0.143 | 0.022 | 0.143 | CDC-like kinase 3 inhibitor | |||
| 0.196 | 0.075 | 0.196 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.151 | 0.033 | 0.151 | Interleukin 8 antagonist | |||
| 0.147 | 0.03 | 0.147 | Activin receptor-like kinase 4 inhibitor | |||
| 0.19 | 0.077 | 0.19 | Focal adhesion kinase 2 inhibitor | |||
| 0.132 | 0.02 | 0.132 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.093 0.045 CID_154699997 | ||
| 0.174 | 0.062 | 0.174 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.218 | 0.106 | 0.218 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.201 | 0.09 | 0.201 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.151 | 0.041 | 0.151 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.147 | 0.038 | 0.147 | Polo-like kinase-4 inhibitor | |||
| 0.154 | 0.045 | 0.154 | Aurora-C kinase inhibitor | |||
| 0.19 | 0.084 | 0.19 | Histone acetyltransferase inhibitor | |||
| 0.11 | 0.007 | 0.11 | MAP kinase kinase 7 inhibitor | |||
| 0.151 | 0.049 | 0.168 | DNA polymerase I inhibitor | 0.168 0.04 CID_154699997 | CID_154699997 | |
| 0.116 | 0.017 | 0.116 | Phosphodiesterase III inhibitor | |||
| 0.118 | 0.02 | 0.118 | Adenosine A2a receptor antagonist | |||
| 0.156 | 0.059 | 0.156 | RET inhibitor | |||
| 0.159 | 0.061 | 0.159 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.186 | 0.089 | 0.186 | Pyruvate kinase inhibitor | |||
| 0.136 | 0.039 | 0.136 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.123 | 0.026 | 0.123 | Phosphodiesterase I inhibitor | |||
| 0.106 | 0.01 | 0.106 | Phosphodiesterase 3B inhibitor | |||
| 0.107 | 0.01 | 0.107 | mTOR inhibitor | |||
| 0.109 | 0.013 | 0.109 | Xanthine dehydrogenase inhibitor | 0.05 0.046 CID_154699997 | ||
| 0.246 | 0.151 | 0.479 | Immunosuppressant | 0.479 0.039 CID_154699997 | CID_154699997 | |
| 0.157 | 0.061 | 0.157 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.156 | 0.061 | 0.156 | Tyrosine-protein kinase receptor antagonist | |||
| 0.12 | 0.025 | 0.12 | Raf kinase inhibitor | |||
| 0.115 | 0.021 | 0.115 | Raf kinase C inhibitor | |||
| 0.157 | 0.064 | 0.157 | CF transmembrane conductance regulator agonist | |||
| 0.116 | 0.023 | 0.116 | Adenosine A2 receptor antagonist | |||
| 0.14 | 0.048 | 0.14 | Protein kinase (CK2) alpha inhibitor | |||
| 0.116 | 0.024 | 0.116 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.133 | 0.044 | 0.133 | MAP kinase 9 inhibitor | |||
| 0.146 | 0.059 | 0.146 | Cyclin-dependent kinase inhibitor | |||
| 0.144 | 0.057 | 0.144 | Protein kinase (CK1) delta inhibitor | |||
| 0.113 | 0.027 | 0.122 | Glutamate release inhibitor | 0.122 0.021 CID_154699997 | CID_154699997 | |
| 0.102 | 0.017 | 0.102 | Secretase beta inhibitor | |||
| 0.151 | 0.066 | 0.151 | Vascular endothelial growth factor 3 antagonist | |||
| 0.144 | 0.06 | 0.144 | Toll-Like receptor antagonist | |||
| 0.109 | 0.026 | 0.109 | Myeloperoxidase inhibitor | |||
| 0.128 | 0.047 | 0.128 | Transcription factor STAT6 inhibitor | |||
| 0.139 | 0.058 | 0.139 | MAP kinase kinase inhibitor | |||
| 0.103 | 0.022 | 0.103 | Adenosine A1 receptor antagonist | |||
| 0.103 | 0.023 | 0.103 | Polo-like kinase-2 inhibitor | |||
| 0.129 | 0.051 | 0.129 | Cystathionine beta-synthase inhibitor | 0.102 0.075 CID_154699997 | ||
| 0.121 | 0.043 | 0.121 | Fibroblast growth factor 1 antagonist | |||
| 0.098 | 0.021 | 0.111 | Phosphodiesterase VI inhibitor | 0.111 0.015 CID_154699997 | CID_154699997 | |
| 0.094 | 0.017 | 0.094 | NMDA 2B receptor antagonist | |||
| 0.102 | 0.027 | 0.102 | D-Ala-D-Ala ligase inhibitor | |||
| 0.099 | 0.025 | 0.099 | Cyclin A2 inhibitor | |||
| 0.133 | 0.059 | 0.133 | TRKA antagonist | |||
| 0.087 | 0.015 | 0.087 | Phosphodiesterase 1C inhibitor | |||
| 0.089 | 0.019 | 0.089 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.095 | 0.025 | 0.095 | MAP3K7 inhibitor | |||
| 0.248 | 0.179 | 0.626 | Antibacterial | 0.626 0.016 CID_154699997 | CID_154699997 | |
| 0.156 | 0.088 | 0.156 | Antipruritic | |||
| 0.09 | 0.024 | 0.09 | Phosphatidylinositol kinase inhibitor | |||
| 0.084 | 0.019 | 0.084 | Cyclin B1 inhibitor | |||
| 0.092 | 0.027 | 0.092 | I kappa B kinase 1 inhibitor | |||
| 0.169 | 0.104 | 0.169 | Interleukin antagonist | |||
| 0.096 | 0.033 | 0.096 | HIV-1 reverse transcriptase inhibitor | |||
| 0.114 | 0.052 | 0.114 | Protein kinase (CK2) inhibitor | |||
| 0.082 | 0.02 | 0.082 | Heat shock protein 90 beta antagonist | |||
| 0.109 | 0.047 | 0.109 | Phosphodiesterase 7B inhibitor | |||
| 0.169 | 0.108 | 0.169 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.09 | 0.029 | 0.09 | CDC7 inhibitor | |||
| 0.086 | 0.027 | 0.086 | Raf kinase B inhibitor | |||
| 0.207 | 0.148 | 0.207 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.083 | 0.024 | 0.083 | 5 Hydroxytryptamine 3 agonist | |||
| 0.066 | 0.008 | 0.066 | Dihydrofolate reductase inhibitor | |||
| 0.077 | 0.019 | 0.077 | Phosphodiesterase II inhibitor | |||
| 0.092 | 0.034 | 0.092 | Transforming growth factor beta 3 antagonist | |||
| 0.098 | 0.041 | 0.098 | AXL receptor tyrosine kinase inhibitor | |||
| 0.075 | 0.018 | 0.075 | Cyclin B2 inhibitor | |||
| 0.116 | 0.059 | 0.116 | 5 Hydroxytryptamine 3A agonist | |||
| 0.084 | 0.029 | 0.084 | Cyclin A inhibitor | |||
| 0.107 | 0.052 | 0.107 | CDK2/cyclin A inhibitor | |||
| 0.073 | 0.019 | 0.073 | Cyclin B inhibitor | |||
| 0.127 | 0.076 | 0.129 | Interleukin 4 antagonist | 0.129 0.073 CID_154699997 | CID_154699997 | |
| 0.119 | 0.068 | 0.222 | Topoisomerase II inhibitor | 0.222 0.029 CID_154699997 | CID_154699997 | |
| 0.076 | 0.025 | 0.076 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.069 | 0.019 | 0.069 | Phosphodiesterase 2A inhibitor | |||
| 0.079 | 0.029 | 0.079 | Glutamate (mGluR7) antagonist | |||
| 0.087 | 0.037 | 0.087 | Purinergic P2X2 antagonist | |||
| 0.095 | 0.046 | 0.095 | Bcr-Abl kinase inhibitor | |||
| 0.11 | 0.063 | 0.11 | Interleukin 2 antagonist | |||
| 0.071 | 0.024 | 0.071 | Bromodomain-containing protein 4 inhibitor | |||
| 0.103 | 0.056 | 0.103 | Creatine kinase inhibitor | |||
| 0.093 | 0.046 | 0.093 | I kappa B kinase inhibitor | |||
| 0.115 | 0.069 | 0.115 | Aurora-B kinase inhibitor | |||
| 0.085 | 0.04 | 0.085 | NMDA 2 receptor antagonist | |||
| 0.128 | 0.085 | 0.128 | Protein kinase (CK1) inhibitor | |||
| 0.1 | 0.058 | 0.1 | Electrolyte absorption antagonist | |||
| 0.091 | 0.049 | 0.091 | TIE antagonist | |||
| 0.085 | 0.044 | 0.085 | Focal adhesion kinase 1 inhibitor | |||
| 0.202 | 0.161 | 0.46 | Immunomodulator | 0.46 0.029 CID_154699997 | CID_154699997 | |
| 0.177 | 0.137 | 0.201 | DNA damaging | 0.201 0.115 CID_154699997 | CID_154699997 | |
| 0.27 | 0.229 | 0.27 | Caspase 9 stimulant | |||
| 0.084 | 0.045 | 0.084 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.075 | 0.036 | 0.075 | CDK1/cyclin B inhibitor | |||
| 0.26 | 0.222 | 0.26 | MAP kinase 1 inhibitor | |||
| 0.19 | 0.153 | 0.19 | MAP kinase kinase 3 inhibitor | |||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | |||
| 0.092 | 0.057 | 0.092 | CDK/cyclin complex inhibitor | |||
| 0.134 | 0.098 | 0.134 | MAP kinase 3 inhibitor | |||
| 0.1 | 0.065 | 0.1 | Check point kinase 2 inhibitor | |||
| 0.094 | 0.06 | 0.094 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.093 | 0.059 | 0.093 | Protein kinase C delta inhibitor | |||
| 0.101 | 0.068 | 0.101 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.121 | 0.088 | 0.121 | Cytokine production inhibitor | |||
| 0.062 | 0.03 | 0.062 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.09 | 0.058 | 0.09 | Pim-3 kinase inhibitor | |||
| 0.072 | 0.04 | 0.072 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.063 | 0.031 | 0.074 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.074 0.024 CID_154699997 | CID_154699997 | |
| 0.116 | 0.086 | 0.116 | Phosphodiesterase inhibitor | |||
| 0.07 | 0.041 | 0.07 | Fibroblast growth factor 2 antagonist | |||
| 0.083 | 0.057 | 0.083 | Protein kinase A inhibitor | |||
| 0.061 | 0.036 | 0.061 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.044 | 0.018 | 0.044 | Glutamate (mGluR group II) agonist | |||
| 0.078 | 0.053 | 0.078 | Fibroblast growth factor 3 antagonist | |||
| 0.118 | 0.093 | 0.118 | Growth factor antagonist | |||
| 0.089 | 0.065 | 0.089 | Hepatocyte growth factor antagonist | |||
| 0.092 | 0.07 | 0.092 | MAP kinase 8 inhibitor | |||
| 0.076 | 0.054 | 0.076 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.069 | 0.046 | 0.069 | Cyclin B3 inhibitor | |||
| 0.08 | 0.057 | 0.08 | TIE-2 antagonist | |||
| 0.071 | 0.049 | 0.071 | Phosphodiesterase 5A inhibitor | |||
| 0.044 | 0.022 | 0.044 | Alpha 1d adrenoreceptor agonist | |||
| 0.158 | 0.136 | 0.231 | Antiamyloidogenic | 0.231 0.08 CID_154699997 | CID_154699997 | |
| 0.119 | 0.098 | 0.119 | Nav1.6 sodium channel blocker | |||
| 0.039 | 0.018 | 0.039 | Glutamate (mGluR2) agonist | |||
| 0.099 | 0.078 | 0.099 | DOPA decarboxylase inhibitor | |||
| 0.098 | 0.077 | 0.098 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.049 | 0.029 | 0.049 | Thymidylate synthase inhibitor | |||
| 0.071 | 0.051 | 0.071 | Janus tyrosine kinase 3 inhibitor | |||
| 0.034 | 0.014 | 0.034 | DNA topoisomerase IV inhibitor | 0.03 0.02 CID_154699997 | ||
| 0.028 | 0.009 | 0.028 | Phosphodiesterase 6A inhibitor | |||
| 0.07 | 0.051 | 0.07 | Phosphodiesterase V inhibitor | |||
| 0.061 | 0.042 | 0.061 | Cyclin D1 inhibitor | |||
| 0.042 | 0.024 | 0.042 | Dihydropteroate synthase inhibitor | |||
| 0.092 | 0.073 | 0.092 | Bronchodilator | |||
| 0.08 | 0.062 | 0.08 | MAP-kinase-activated kinase inhibitor | |||
| 0.087 | 0.069 | 0.087 | Alcohol dehydrogenase inhibitor | |||
| 0.049 | 0.032 | 0.049 | Histamine H4 receptor antagonist | |||
| 0.066 | 0.049 | 0.066 | Check point kinase 1 inhibitor | |||
| 0.075 | 0.059 | 0.075 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.091 | 0.075 | 0.091 | Nitric-oxide synthase inhibitor | |||
| 0.035 | 0.019 | 0.035 | Protein kinase (CK2) beta inhibitor | |||
| 0.054 | 0.039 | 0.054 | Protein kinase C eta inhibitor | |||
| 0.044 | 0.03 | 0.044 | AICAR transformylase inhibitor | |||
| 0.044 | 0.03 | 0.044 | Guanylate cyclase stimulant | |||
| 0.053 | 0.039 | 0.053 | Lysine-specific demethylase 1A inhibitor | |||
| 0.09 | 0.077 | 0.09 | Insulin receptor antagonist | |||
| 0.083 | 0.07 | 0.083 | Bromodomain-containing protein 2 inhibitor | |||
| 0.058 | 0.046 | 0.058 | Phosphodiesterase 1A inhibitor | |||
| 0.039 | 0.027 | 0.039 | Cyclin D3 inhibitor | |||
| 0.03 | 0.018 | 0.03 | CDK4/cyclin D3 inhibitor | |||
| 0.056 | 0.044 | 0.056 | CDK4/cyclin D inhibitor | |||
| 0.048 | 0.037 | 0.048 | Phosphatidylinositol 3-kinase beta inhibitor | |||
| 0.168 | 0.158 | 0.168 | Superoxide dismutase inhibitor | |||
| 0.019 | 0.009 | 0.022 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.022 0.005 CID_154699997 | CID_154699997 | |
| 0.069 | 0.061 | 0.069 | Adenosine A3 receptor antagonist | |||
| 0.086 | 0.078 | 0.151 | Xanthine oxidase inhibitor | 0.151 0.034 CID_154699997 | CID_154699997 | |
| 0.019 | 0.012 | 0.019 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.047 | 0.04 | 0.047 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.068 | 0.061 | 0.068 | Protein kinase B beta inhibitor | |||
| 0.052 | 0.047 | 0.052 | Fatty acid synthase inhibitor | |||
| 0.045 | 0.04 | 0.045 | Adenosine A2b receptor antagonist | |||
| 0.038 | 0.033 | 0.038 | CDK5/p25 inhibitor | |||
| 0.046 | 0.041 | 0.046 | Dopamine beta hydroxylase inhibitor | |||
| 0.13 | 0.126 | 0.203 | Interleukin 6 antagonist | 0.203 0.039 CID_154699997 | CID_154699997 | |
| 0.062 | 0.058 | 0.062 | CDK1/cyclin B1 inhibitor | |||
| 0.163 | 0.16 | 0.163 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.034 | 0.031 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.064 | 0.061 | 0.064 | Protein kinase C beta inhibitor | |||
| 0.082 | 0.079 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.061 | 0.059 | 0.061 | Syk tyrosine kinase inhibitor | |||
| 0.083 | 0.081 | 0.083 | Aurora-A kinase inhibitor | |||
| 0.062 | 0.06 | 0.062 | MAP kinase kinase 8 inhibitor | |||
| 0.079 | 0.078 | 0.079 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.041 | 0.04 | 0.041 | Adenosine deaminase inhibitor | |||
| 0.042 | 0.041 | 0.042 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.128 | 0.131 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.111 CID_154699997 | CID_154699997 | |
| 0.044 | 0.05 | 0.056 | Cytokine production stimulant | 0.056 0.018 CID_154699997 | CID_154699997 | |
| 0.115 | 0.126 | 0.228 | Hexokinase inhibitor | 0.228 0.023 CID_154699997 | CID_154699997 | |
| 0.113 | 0.13 | 0.403 | Hemostatic | 0.403 0.008 CID_154699997 | CID_154699997 | |
| 0.088 | 0.105 | 0.19 | Alkylator | 0.19 0.029 CID_154699997 | CID_154699997 | |
| 0.048 | 0.073 | 0.075 | DNA gyrase inhibitor | 0.075 0.031 CID_154699997 | CID_154699997 | |
| 0.175 | 0.206 | 0.357 | Vasodilator, coronary | 0.357 0.052 CID_154699997 | CID_154699997 | |
| 0.077 | 0.109 | 0.134 | DNA intercalator | 0.134 0.05 CID_154699997 | CID_154699997 | |
| 0.057 | 0.104 | 0.079 | Interferon agonist | 0.079 0.054 CID_154699997 | CID_154699997 | |
| 0.049 | 0.098 | 0.11 | Topoisomerase II alpha inhibitor | 0.11 0.034 CID_154699997 | CID_154699997 | |
| 0.066 | 0.116 | 0.11 | NADH dehydrogenase inhibitor | 0.11 0.035 CID_154699997 | CID_154699997 | |
| 0.075 | 0.128 | 0.111 | Phosphodiesterase 6D inhibitor | 0.111 0.035 CID_154699997 | CID_154699997 | |
| 0.067 | 0.121 | 0.106 | Thioredoxin inhibitor | 0.106 0.041 CID_154699997 | CID_154699997 | |
| 0.034 | 0.09 | 0.092 | Factor IXa inhibitor | 0.092 0.012 CID_154699997 | CID_154699997 | |
| 0.06 | 0.119 | 0.177 | Topoisomerase I inhibitor | 0.177 0.032 CID_154699997 | CID_154699997 | |
| 0.037 | 0.096 | 0.096 | Phosphofructokinase-1 inhibitor | 0.096 0.033 CID_154699997 | CID_154699997 | |
| 0.07 | 0.138 | 0.1 | Interleukin 12 antagonist | 0.1 0.054 CID_154699997 | CID_154699997 | |
| 0.076 | 0.153 | 0.112 | Photosensitizer | 0.112 0.068 CID_154699997 | CID_154699997 | |
| 0.05 | 0.151 | 0.135 | Mediator release inhibitor | 0.135 0.036 CID_154699997 | CID_154699997 | |
| 0.107 | 0.212 | 0.138 | CC chemokine 6 receptor antagonist | 0.138 0.044 CID_154699997 | CID_154699997 | |
| 0.199 | 0.31 | 0.258 | 5 Hydroxytryptamine release inhibitor | 0.258 0.217 CID_154699997 | CID_154699997 | |
| 0.088 | 0.202 | 0.221 | Insulin secretagoues | 0.221 0.027 CID_154699997 | CID_154699997 | |
| 0.133 | 0.249 | 0.347 | Peptidyltransferase inhibitor | 0.347 0.013 CID_154699997 | CID_154699997 | |
| 0.129 | 0.253 | 0.416 | Transcription factor NF kappa B inhibitor | 0.416 0.06 CID_154699997 | CID_154699997 | |
| 0.061 | 0.196 | 0.087 | T cell inhibitor | 0.087 0.044 CID_154699997 | CID_154699997 | |
| 0.088 | 0.223 | 0.184 | DNA methylase inhibitor | 0.184 0.09 CID_154699997 | CID_154699997 | |
| 0.148 | 0.302 | 0.365 | Interleukin 2 agonist | 0.365 0.039 CID_154699997 | CID_154699997 | |
| 0.079 | 0.238 | 0.2 | NOS3 expression enhancer | 0.2 0.041 CID_154699997 | CID_154699997 | |
| 0.056 | 0.22 | 0.142 | Toll-Like receptor 4 antagonist | 0.142 0.026 CID_154699997 | CID_154699997 | |
| 0.044 | 0.211 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 CID_154699997 | CID_154699997 | |
| 0.069 | 0.241 | 0.201 | Cell wall synthesis inhibitor | 0.201 0.029 CID_154699997 | CID_154699997 | |
| 0.094 | 0.27 | 0.194 | ATPase inhibitor | 0.194 0.042 CID_154699997 | CID_154699997 | |
| 0.137 | 0.315 | 0.208 | Caspase 3 stimulant | 0.208 0.158 CID_154699997 | CID_154699997 | |
| 0.05 | 0.23 | 0.184 | Lipid peroxidase inhibitor | 0.184 0.049 CID_154699997 | CID_154699997 | |
| 0.014 | 0.194 | 0.047 | Mannosidase inhibitor | 0.047 0.029 CID_154699997 | CID_154699997 | |
| 0.085 | 0.272 | 0.343 | Tumour necrosis factor alpha release inhibitor | 0.343 0.04 CID_154699997 | CID_154699997 | |
| 0.023 | 0.218 | 0.082 | Heparanase inhibitor | 0.082 0.006 CID_154699997 | CID_154699997 | |
| 0.018 | 0.214 | 0.053 | Alpha-mannosidase inhibitor | 0.053 0.038 CID_154699997 | CID_154699997 | |
| 0.061 | 0.261 | 0.111 | Protein kinase stimulant | 0.111 0.103 CID_154699997 | CID_154699997 | |
| 0.07 | 0.274 | 0.224 | Interleukin agonist | 0.224 0.099 CID_154699997 | CID_154699997 | |
| 0.039 | 0.248 | 0.082 | Uric acid excretion stimulant | 0.082 0.079 CID_154699997 | CID_154699997 | |
| 0.022 | 0.235 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 CID_154699997 | CID_154699997 | |
| 0.042 | 0.257 | 0.153 | AMP-activated protein kinase stimulant | 0.153 0.026 CID_154699997 | CID_154699997 | |
| 0.077 | 0.303 | 0.138 | Interferon gamma antagonist | 0.138 0.096 CID_154699997 | CID_154699997 | |
| 0.056 | 0.29 | 0.13 | Diuretic | 0.13 0.095 CID_154699997 | CID_154699997 | |
| 0.063 | 0.307 | 0.352 | Immunostimulant | 0.352 0.064 CID_154699997 | CID_154699997 | |
| 0.066 | 0.317 | 0.362 | Free radical scavenger | 0.362 0.036 CID_154699997 | CID_154699997 | |
| 0.064 | 0.317 | 0.325 | Hepatoprotectant | 0.325 0.023 CID_154699997 | CID_154699997 | |
| 0.008 | 0.272 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 CID_154699997 | CID_154699997 | |
| 0.015 | 0.293 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 CID_154699997 | CID_154699997 | |
| 0.066 | 0.353 | 0.392 | Antioxidant | 0.392 0.036 CID_154699997 | CID_154699997 | |
| 0.087 | 0.375 | 0.236 | Cholesterol antagonist | 0.236 0.135 CID_154699997 | CID_154699997 | |
| 0.034 | 0.323 | 0.233 | Thrombolytic | 0.233 0.038 CID_154699997 | CID_154699997 | |
| 0.02 | 0.332 | 0.095 | Expectorant | 0.095 0.075 CID_154699997 | CID_154699997 | |
| 0.112 | 0.44 | 0.418 | Apoptosis agonist | 0.418 0.105 CID_154699997 | CID_154699997 | |
| 0.055 | 0.385 | 0.219 | Vasodilator | 0.219 0.091 CID_154699997 | CID_154699997 | |
| 0.037 | 0.375 | 0.501 | Angiogenesis stimulant | 0.501 0.012 CID_154699997 | CID_154699997 | |
| 0.007 | 0.35 | 0.102 | Antineoplastic antibiotic | 0.102 0.045 CID_154699997 | CID_154699997 | |
| 0.106 | 0.46 | 0.657 | Cyclophilin D inhibitor | 0.657 0.019 CID_154699997 | CID_154699997 | |
| 0.072 | 0.428 | 0.431 | Antithrombotic | 0.431 0.042 CID_154699997 | CID_154699997 | |
| 0.043 | 0.42 | 0.244 | Nitric oxide antagonist | 0.244 0.053 CID_154699997 | CID_154699997 | |
| 0.012 | 0.409 | 0.079 | Protein 50S ribosomal subunit inhibitor | 0.079 0.02 CID_154699997 | CID_154699997 | |
| 0.034 | 0.452 | 0.115 | Cyclooxygenase 3 inhibitor | 0.115 0.084 CID_154699997 | CID_154699997 | |
| 0.007 | 0.484 | 0.286 | Selectin antagonist | 0.286 0.006 CID_154699997 | CID_154699997 | |
| 0.026 | 0.518 | 0.162 | Cell adhesion inhibitor | 0.162 0.039 CID_154699997 | CID_154699997 | |
| 0.02 | 0.529 | 0.158 | Anticoagulant | 0.158 0.073 CID_154699997 | CID_154699997 | |
| 0.066 | 0.578 | 0.305 | Apoptosis antagonist | 0.305 0.082 CID_154699997 | CID_154699997 | |
| 0.01 | 0.568 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 CID_154699997 | CID_154699997 | |
| 0.01 | 0.609 | 0.072 | Cell adhesion molecule inhibitor | 0.072 0.066 CID_154699997 | CID_154699997 | |
| 0.016 | 0.631 | 0.172 | Platelet antagonist | 0.172 0.124 CID_154699997 | CID_154699997 | |
| 0.013 | 0.645 | 0.09 | ATPase (Vacuolar H+) inhibitor | 0.09 0.056 CID_154699997 | CID_154699997 | |
| 0.03 | 0.707 | 0.433 | Hypoglycemic | 0.433 0.023 CID_154699997 | CID_154699997 | |
| 0.025 | 0.709 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 CID_154699997 | CID_154699997 | |
| 0.012 | 0.844 | 0.197 | Platelet adhesion inhibitor | 0.197 0.073 CID_154699997 | CID_154699997 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |